ALCO
Alico, Inc.
There isn't enough reported data to score ALCO yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
ALCO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Weak | |
| Weak |
ALCO's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ALCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $1.07 | -97% |
| Fair | 7.6x | $1.59 | -96% |
| Expensive | 11x | $2.39 | -94% |
| Current | 177x | $37.14 | — |
Historical ranges are pointers, not guarantees.
ALCO's PE is 177x, but its earnings don't support one, so it isn't a reliable read right now.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over ALCO in the historical PE scenario, which offers more potential upside but is not a forecast.
ALCO Forward outlook
There aren't enough analyst estimates for ALCO to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
ALCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.21 | +$20.77 |
| Q1 2026 | -$2.47 | +$15.97 |
| Q4 2025 | -$18.54 | -$12.61 |
| Q3 2025 | -$19.29 | -2220% |
| Q2 2025 | -$20.56 | -703% |
| Q1 2025 | -$18.44 | -452% |
| Q4 2024 | -$5.93 | -194% |
| Q3 2024 | $0.91 | +279% |
ALCO has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
ALCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $9M | +7.7% |
| Q1 2026 | $5.3M | -70% |
| Q4 2025 | $1.9M | -89% |
| Q3 2025 | $802K | -14% |
| Q2 2025 | $8.4M | -38% |
| Q1 2025 | $18M | -0.7% |
| Q4 2024 | $16.9M | +21% |
| Q3 2024 | $935K | +38% |
ALCO's revenue is recovering but still below its 2021 peak: $9M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | +389 points |
| Q1 2026 | -146% | +705 points |
| Q4 2025 | -453% | -389 points |
| Q3 2025 | -1131% | +1299 points |
| Q2 2025 | -369% | -319 points |
| Q1 2025 | -851% | -738 points |
| Q4 2024 | -64% | +61 points |
| Q3 2024 | -2430% | -2215 points |
ALCO has the edge over CELH on profitability, with a higher operating margin.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over ALCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
ALCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.6M | -71% |
| Q1 2026 | -$60K | -101% |
| Q4 2025 | -$6M | +$4.7M |
| Q3 2025 | -$4.2M | +$9.5M |
| Q2 2025 | $22.8M | +$26.2M |
| Q1 2025 | $6.6M | +$21.2M |
| Q4 2024 | -$10.6M | +$6M |
| Q3 2024 | -$13.7M | -$4.3M |
ALCO has burned cash in most quarters: −$4M over the past year, against $5M the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over ALCO on cash generation, producing positive trailing cash flow while its opponent burns cash.
ALCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.7% | -203K shares |
| 1 year | -2.7% | -204K shares |
| 3 years | -2.1% | -156K shares |
| 5 years | -0.9% | -66K shares |
| Available history | -0.7% | -56K shares |
ALCO has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1.6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $238,000 |
| Q3 2019 | — |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
ALCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 6.5x | High |
| Q3 2023 | 9.1x | High |
| Q2 2022 | -0.3x | Net Cash |
| Q1 2022 | -1.0x | Net Cash |
| Q4 2021 | 0.5x | Very low |
| Q3 2021 | 0.1x | Very low |
| Q2 2021 | -0.8x | Net Cash |
| Q1 2021 | -0.1x | Net Cash |
ALCO's net debt is about 6.5 years of its operating earnings (EBITDA), up from less than a year a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
ALCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 9.1 | Oversold |
ALCO's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
ALCO PE vs Consumer Defensive Sector
| Metric | ALCO | Sector median | Relative |
|---|---|---|---|
| PE | 177x | 19x | 807% above |
| PE % | 96 | 18 | 78 pts above |
ALCO is trading at 177x earnings, a 807% premium to the Consumer Defensive sector's median of 19x, though its earnings don't support one.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over ALCO on valuation relative to its sector.
ALCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.7 | 1.5% below |
| 20 week MA | $39.0 | 4.8% below |
| 50 week MA | $39.7 | 6.4% below |
| 100 week MA | $35.5 | 4.6% above |
| 200 week MA | $31.0 | 20% above |
ALCO has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 20% above its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
ALCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.0 | $31.5 | -13% |
| 2021 | $31.5 | $36.2 | +15% |
| 2022 | $36.2 | $23.9 | -34% |
| 2023 | $23.9 | $29.1 | +22% |
| 2024 | $29.1 | $25.5 | -12% |
| 2025 | $25.5 | $36.6 | +44% |
| 2026 YTD | $36.6 | $37.1 | +1.4% |
ALCO has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.